Company Filing History:
Years Active: 2012-2018
Title: David MacDonald: Innovator in Pharmacokinetics
Introduction: David MacDonald is a distinguished inventor based in Surrey, Canada, known for his contributions to the field of pharmacokinetics. With a total of seven patents, he has focused on improving the absorption and efficacy of S-adenosylmethionine (SAMe) formulations. His innovations are significant in the treatment of various disorders, showcasing his commitment to advancing medical science and enhancing patient care.
Latest Patents: Among MacDonald's latest patents are two notable inventions centered on the pharmacokinetics of S-adenosylmethionine. The first patent details compositions and methods designed to improve the pharmacokinetic profile of SAMe, allowing for enhanced treatment of various diseases. This invention specifically emphasizes administering compositions to subjects once a day after an overnight fast, maximizing nutrient absorption for better therapeutic outcomes.
The second patent focuses on compositions comprising S-adenosyl-L-methionine combined with one or more gallic acid esters. This innovation aims to improve delivery systems for SAMe, significantly increasing plasma concentrations and optimizing therapeutical efficiency. By combining these elements, the methods outlined in his patents provide pathways for treating disorders while improving nutritional status.
Career Highlights: MacDonald is currently associated with Methylation Sciences International Srl, where he continues to contribute to innovative research and development in the field of nutrition and health. His work underscores the critical intersection of pharmacology and nutrition, aiming to create beneficial formulations for healthcare.
Collaborations: Throughout his career, MacDonald has collaborated with talented professionals, including Nancy Harrison and Aniko Takacs-Cox. These partnerships have aided in the development and practical application of his groundbreaking research, further enhancing the reach and impact of his inventions in the health sector.
Conclusion: David MacDonald stands as a significant figure in the realm of pharmacokinetics, with his inventive spirit leading to advancements that can potentially change treatment paradigms for various disorders. His ongoing research and innovations at Methylation Sciences International Srl promise to maintain a strong influence in the industry, benefitting both healthcare practitioners and patients alike.